Advisornet Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $440 | Buy |
8
+4
| +100% | +$220 | ﹤0.01% | 2051 |
|
2025
Q1 | $283 | Sell |
4
-2
| -33% | -$142 | ﹤0.01% | 2023 |
|
2024
Q4 | $394 | Buy |
+6
| New | +$394 | ﹤0.01% | 1796 |
|
2024
Q2 | – | Sell |
-10
| Closed | -$873 | – | 2075 |
|
2024
Q1 | $873 | Sell |
10
-386
| -97% | -$33.7K | ﹤0.01% | 1793 |
|
2023
Q4 | $38.2K | Buy |
396
+9
| +2% | +$868 | ﹤0.01% | 892 |
|
2023
Q3 | $34.2K | Sell |
387
-118
| -23% | -$10.4K | ﹤0.01% | 883 |
|
2023
Q2 | $43.8K | Sell |
505
-2,128
| -81% | -$184K | ﹤0.01% | 848 |
|
2023
Q1 | $256K | Sell |
2,633
-6,828
| -72% | -$664K | 0.02% | 424 |
|
2022
Q4 | $979K | Buy |
9,461
+26
| +0.3% | +$2.69K | 0.1% | 205 |
|
2022
Q3 | $800K | Buy |
9,435
+125
| +1% | +$10.6K | 0.08% | 240 |
|
2022
Q2 | $772K | Buy |
9,310
+360
| +4% | +$29.9K | 0.08% | 246 |
|
2022
Q1 | $690K | Buy |
8,950
+1,418
| +19% | +$109K | 0.04% | 312 |
|
2021
Q4 | $665K | Buy |
7,532
+758
| +11% | +$66.9K | 0.04% | 341 |
|
2021
Q3 | $524K | Buy |
6,774
+717
| +12% | +$55.5K | 0.04% | 357 |
|
2021
Q2 | $505K | Buy |
6,057
+331
| +6% | +$27.6K | 0.03% | 378 |
|
2021
Q1 | $432K | Buy |
5,726
+905
| +19% | +$68.3K | 0.03% | 387 |
|
2020
Q4 | $423K | Buy |
4,821
+115
| +2% | +$10.1K | 0.03% | 369 |
|
2020
Q3 | $358K | Hold |
4,706
| – | – | 0.03% | 389 |
|
2020
Q2 | $580K | Hold |
4,706
| – | – | 0.05% | 312 |
|
2020
Q1 | $398K | Buy |
4,706
+580
| +14% | +$49.1K | 0.04% | 353 |
|
2019
Q4 | $349K | Hold |
4,126
| – | – | 0.03% | 394 |
|
2019
Q3 | $278K | Hold |
4,126
| – | – | 0.03% | 438 |
|
2019
Q2 | $353K | Buy |
4,126
+778
| +23% | +$66.6K | 0.04% | 363 |
|
2019
Q1 | $297K | Sell |
3,348
-138
| -4% | -$12.2K | 0.04% | 369 |
|
2018
Q4 | $297K | Buy |
3,486
+7
| +0.2% | +$596 | 0.04% | 335 |
|
2018
Q3 | $337K | Sell |
3,479
-160
| -4% | -$15.5K | 0.04% | 329 |
|
2018
Q2 | $343K | Hold |
3,639
| – | – | 0.05% | 297 |
|
2018
Q1 | $295K | Hold |
3,639
| – | – | 0.04% | 323 |
|
2017
Q4 | $324K | Buy |
+3,639
| New | +$324K | 0.05% | 266 |
|